Table 2.
Probiotic viability of commercial microorganisms before and after gastrointestinal simulation. Analysis performed on 1g of sample.
| Sample |
Gastrointestinal simulation |
|||
|---|---|---|---|---|
| Lactobacillus sp. | Initial | Stomach | Duodenum | Ileum |
| IP1 | 8.2 ± 0.1a | 8.0 ± 0.1 | 7.9 ± 0.1 | 7.7 ± 0.1 |
| IP2 | 9.8 ± 0.2 | 8.7 ± 0.1 | 8.0 ± 0.1 | 8.1 ± 0.1 |
| IP3 | 10.5 ± 0.1 | 9.4 ± 0.2 | 9.3 ± 0.1 | 9.0 ± 0.1 |
| MP4 | 5.8 ± 0.1 | 3.2 ± 0.1 | 3.0 ± 0.2 | 3.0 ± 0.1 |
| MP5 | 4.8 ± 0.2 | 3.6 ± 0.1 | 3.3 ± 0.1 | 3.2 ± 0.1 |
| CP6 | 9.9 ± 0.1 | 7.1 ± 0.1 | 7.1 ± 0.3 | 7.0 ± 0.1 |
| CP7 | 10.7 ± 0.2 | 9.4 ± 0.1 | 8.3 ± 0.1 | 8.6 ± 0.1 |
| CP8 | 6.5 ± 0.2 | 4.4 ± 0.2 | 3.3 ± 0.1 | 2.9 ± 0.1 |
| CP9 | 7.3 ± 0.1 | 5.8 ± 0.2 | 5.8 ± 0.2 | 5.8 ± 0.1 |
| Bifidobacterium sp. | ||||
| CP7 | 10.5 ± 0.2 | 9.2 ± 0.2 | 7.3 ± 0.1 | 7.2 ± 0.1 |
| CP8 | 7.7 ± 0.1 | 3.3 ± 0.1 | 3.6 ± 0.1 | 3.5 ± 0.1 |
| PC9 | 5.6 ± 0.2 | 5.4 ± 0.1 | 5.2 ± 0.1 | 5.1 ± 0.2 |
| FM10 | 8.0 ± 0.1 | 6.7 ± 0.2 | 6.9 ± 0.1 | 6.9 ± 0.2 |
| MP11 | 4.3 ± 0.1 | 3.5 ± 0.1 | 3.3 ± 0.2 | 3.3 ± 0.1 |
a
Triplicate means followed by the standard deviation. Results expressed in log CFU g−1.